NUS Students Visit to Explore the World of Drug Discovery
On 7 April 2025, we had the opportunity to host an industry visit for 11 students from the National University of Singapore (NUS).
This was a chance for the students to connect the dots between academic studies and real-world applications in the biopharma industry. It was also a valuable moment for us to share our expertise and showcase our work.
The group of 11 consisted of undergraduates enrolled in the Molecular Biotechnology module, as well as postgraduate students from the Master of Science in Biotechnology programme at NUS.
We started the visit with a brief background of what we do as part of the Chugai Group. Scientists and Research Associates from our Lead Optimization and Pharmacology units then gave the students a history and overview of our drug discovery process, from early-stage research and target identification to clinical trials.
They also provided an explanation of our proprietary antibody engineering technologies such as our Recycling Antibody Technology which has been used to develop innovative drugs that can deliver better clinical outcomes for patients.
Our Safety Team then walked the students through the rigorous safety standards we maintain in our laboratories and scientific work, which is integral to successful drug development.
The lab tour was a highlight as the students could take a look what goes on behind the scenes when it comes to drug discovery. Seeing the throughput screening machines and other equipment gave them a sense of how technology plays a critical role in drug discovery.
The visit concluded with an informal Q&A session. The students were eager to learn more about the industry, with many taking the opportunity to ask follow-up questions with NUS alumni who are now working in our company.
It’s always a pleasure to welcome science students to our space, where we can contribute to the development of the scientific community and help shape the careers of future scientists.
